Novavax's updated vaccine targets a variant called JN.1, which is in line with European recommendations. The European Union's regulator tol...

The researchers from Pennsylvania State University, US, said that such a vaccine may provide long-lasting immunity against future emerging ...

Even when Omicron variants like BF.7 are exhibiting increased capacity for evading immunity, antibody surge from boosters may prevent sever...

The supply of protein subunit vaccines as the best booster choice should be increased, Anurag Agrawal, former head of the Indian SARS-CoV-2...

Novavax's protein-based vaccine was approved for emergency use by the US Food and Drug Administration (USFDA) last month in India.

Protein-based covid shot, Novavax has received a recommendation by US Food and drug administration(FDA), which can make it the 4th option f...

India's drug regulator had on December 28 granted emergency use authorisation (EUA) to Covovax. However, with the government not planning t...

Meanwhile, India logged 653 cases of the Omicron variant of coronavirus across 21 states and UTs so far out of which 186 have recovered or ...

The vaccine will be produced and distributed by a joint venture between the UAE's Group 42 and China National Biotec Group (CNBG), a unit o...

The research team at Boston Children's Hospital, US, noted that currently available Covid vaccines require cold storage and sophisticated m...

The researchers deel developing vaccines to activate the other arm of the immune system -- the T cells -- could dramatically increase immun...

"Safe and effective vaccines for young children will help limit the spread of COVID-19 because we know children can transmit the virus to o...

The researchers, in a study not yet reviewed by experts, said COVID-19 vaccines that employ adenovirus vectors - cold viruses used to deliv...

The vaccines currently being developed by Novavax and Sanofi/Glaxo-Smith-Kline are examples of protein-based vaccines.

The decision on procuring the right COVID-19 vaccine depends on multiple factors, including safety, price and ease of deployment, the scien...

Moderna Inc. and competitor Pfizer Inc. recently announced preliminary results showing their vaccines appear more than 90% effective, at le...

In two studies published in the past week, they reported the design of a 'heat-tolerant' Covid-19 vaccine candidate and a rapid method to i...